Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High levels of adherence do not prevent accumulation of HIV drug resistance mutations.

AIDS (London, England) - 5 Sept 2003

Bangsberg David R, Charlebois Edwin D, Grant Robert M, Holodniy Mark, Deeks Steven G, Perry Sharon, Conroy Kathleen Nugent, Clark Richard, Guzman David, Zolopa Andrew, Moss Andrew

Abstract excerpt

OBJECTIVES: To assess the relationship between development of antiretroviral drug resistance and adherence by measured treatment duration, virologic suppression, and the rate of accumulating new drug resistance mutations at different levels of adherence. METHODS: Adherence was measured with unannounced pill counts performed at the participant's usual place of residence in a prospective cohort of HIV-positive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Administration Schedule

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Patient Compliance

Share to Urban Health

Share to Viral Load

Source

Identifiers

PMID: 12960825
DOI: 10.1097/00002030-200309050-00011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High levels of adherence do not prevent accumulation of HIV drug resistance mutations.PMID 12960825Read ↗

Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.Semantic proximity Read ↗

Assessing the impact of adherence to anti-retroviral therapy on treatment failure and resistance evolution in HIV.Semantic proximity Read ↗

Modeling the HIV Protease Inhibitor Adherence–Resistance Curve by Use of Empirically Derived EstimatesSemantic proximity Read ↗

Antiretroviral dynamics determines HIV evolution and predicts therapy outcome.Semantic proximity Read ↗

HIV-1 drug resistance evolution among patients on potent combination antiretroviral therapy with detectable viremia.Semantic proximity Read ↗

The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes.Semantic proximity Read ↗

Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation.Semantic proximity Read ↗

Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, IndiaSemantic proximity Read ↗

Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda.Semantic proximity Read ↗

Association Between Medication Possession Ratio, Virologic Failure and Drug Resistance in HIV-1–Infected Adults on Antiretroviral Therapy in Côte d'IvoireSemantic proximity Read ↗

Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation.Semantic proximity Read ↗

No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.